Skip to main content
. 2017 Jul 25;7:6413. doi: 10.1038/s41598-017-06844-2

Figure 1.

Figure 1

Hyperoside pre-treatment alleviated renal cortex oxidative stress and heparanase protein expression in DN mice (n = 15). (A) The levels of ROS-related end product MDA in renal cortex were measured among indicated groups. (BD) The activity of ROS-related enzymes SOD, CAT and XO was measured among indicated groups. (E,F) Renal cortex heparanase protein expression was detected by western blot analysis and the columns showed the relative quatification of heparanase protein levels normalized to β-actin. Control: Normal mice; DN: DM mice were treated with vehicle solution for four weeks; LHPS and HHPS: DM mice were treated with 10 or 30 mg/kg/d hyperoside for four weeks respectively from two weeks after DM establishment. Data are presented as mean ± SD. P < 0.05 is statistically significant. aIndicates significant vs. Control, bindicates significant vs. DN.